Skip to content
Bored Studies
RecruitingPhase 3

Brexanolone Lifting Outcomes Of Moms

Lipocine Inc. · NCT07822321

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 15–45 · Women only
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Phase 3
Target enrollment
120
US sites recruiting
16
Study start
September 2026
Record last updated
September 16, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this research study is to test the study drug, LPCN 1154A, as a possible treatment for postpartum depression (PPD). The trial aims to determine:

  • If LPCN 1154A reduces depressive symptoms in subjects with severe PPD
  • How well LPCN 1154A is tolerated and what side effects it may cause

Being studied: LPCN 1154A; Placebo

Conditions: Depression, Postpartum; Postpartum Depression (PPD); Post-partum Depression; Postnatal Depression; Post-Natal Depression; Peripartum Depression

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Key Inclusion Criteria

  • Are female between 15 and 45 years of age, inclusive;
  • Have had a depressive episode that began no earlier than second trimester and no later than the first 4 weeks following delivery
  • Are \< 18 months postpartum at Screening
  • Hamilton Depression Rating Scale (HAM-D) 17-item score indicative of severe depression

Key Exclusion Criteria

  • Have a history of bipolar disorder, schizophrenia or schizoaffective disorder
  • Are currently experiencing active psychosis per Investigator assessment
  • Have a history of suicidal behavior associated with the current depressive episode
  • Have a history of seizure within six months of Screening

Recruiting US locations

Study contacts (from the official record)

  • Vice President of Clinical Development · 801-519-4363 · siteinquiry@lipocine.com
All mental health studies in Arizona →